Skip to content

The Short and Long-term Cardiovascular Consequences of Critical Illness: The C3 Study

The Short and Long-term Cardiovascular Consequences of Critical Illness: The C3 Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04545437
Acronym
C3
Enrollment
80000
Registered
2020-09-11
Start date
2020-08-10
Completion date
2023-12-31
Last updated
2023-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Flutter, Atrium; Fibrillation, Critical Illness, Myocardial Infarction, Stroke

Brief summary

The aim this study will be to find out which patients are at risk of heart attacks/strokes up to several years after discharge from an ICU. This study will also investigate whether treatments and events occurring in ICU contribute to this risk.

Detailed description

Undertake a retrospective observational cohort study of patients admitted to intensive care units between 2006 and 2023. Study Participants: Adult patients admitted to a general adult intensive care unit at one or more of the study sites between 2006 and 1st of August 2023. Objectives: To determine the short and long-term cardiovascular consequences of critical illness and identify in-ICU factors that affect them. To identify the risk factors for new-onset atrial fibrillation/flutter occurring during critical illness. To study the association between poor cardiovascular function during critical illness and long-term cardiovascular disease. This study will provide new knowledge about the associations between baseline cardiovascular risk, the disease resulting in ICU admission and therapies / events on ICU with subsequent major adverse cardiac events (MACE), to allow the ongoing risk of these events to be determined. If clinicans can idetnify who is at risk, then risk factors can potentially be modified .

Interventions

Exposure is admission to an Intensive Care Unit

Sponsors

University of Oxford
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 16 years or above. * Admitted to an intensive care unit at a study site from 2006 onwards

Exclusion criteria

* Patients that have informed their participating site that they do not wish their electronic records would be used for future research * Patients who inform us directly that they don't wish their records used in this research study

Design outcomes

Primary

MeasureTime frame
Mortality5 years
Major adverse cardiovascular and vascular events5 years
Arrhythmia5 years

Secondary

MeasureTime frame
Hospital re-admission5 years

Countries

United Kingdom

Contacts

Primary ContactRobert Hatch
robert.hatch@ndcn.ox.ac.uk+44 (0) 1865 231456
Backup ContactJonathan Bedford
jonathan.bedford@ndcn.ox.ac.uk+44 (0) 1865 231456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026